Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

Laza-Briviesca, R; Cruz-Bermúdez, A; Nadal, E; Insa, A; García-Campelo, MD; Huidobro, G; Dómine, M; Majem, M; Rodríguez-Abreu, D; Martínez-Martí, A; Carpeño, JD; Cobo, M; Vivanco, GL; Del Barco, E; Caro, RB; Viñolas, N; Aranda, IB; Viteri, S; Massuti, B; Casarrubios, M; Sierra-Rodero, B; Tarín, C; García-Grande, A; Haymaker, C; Wistuba, II; Romero, A; Franco, F; Provencio, M – 2021 – 10.1002/ctm2.491